# OnCo record bantam-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bantam-pharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bantam-pharmaceutical" ;
  schema:name "Bantam Pharmaceutical"@en ;
  schema:alternateName "Bantam Pharmaceuticals"@en ;
  schema:description "Bantam Pharmaceutical is developing BTM-3566, a medicine taken by mouth that acts on the cell's mitochondria to push cancer cells into self-destruction. It is in early trials in B-cell lymphomas and advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/bantam-pharmaceutical/>, <https://bantampharma.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://bantampharma.com/>, <https://bantampharma.com/news-resources/>, <https://bantampharma.com/news-2021-09-16/>, <https://clinicaltrials.gov/study/NCT06792734>, <https://clinicaltrials.gov/study/NCT07266285> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> .